Carlos Gil Ferreira

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Lymph Node Metastasis

Affordable Care Act

Radiation Therapy

Top Venues

JCO global oncology

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Journal of market access & health policy

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Bruna Bianca Lopes David, Pedro Nazareth Aguiar, Matheus Costa E Silva, Rodrigo Dienstmann, Carlos Gil Ferreira, Cesar Serrano
Cost Evaluation Analysis of Genetic Testing and Tailored Adjuvant Imatinib in Patients With Resected High-Risk GI Stromal Tumors: The Brazilian Perspective. JCO global oncology 9 (2023)
Tatiane Montella, Mariano Zalis, Mauro Zukin, Vladmir Cláudio Cordeiro de Lima, Clarissa Seródio Baldotto, Pedro De Marchi, Paulo Guilherme de Oliveira Salles, Clarissa Mathias, Carlos Henrique Barrios, Carolina Kawamura, Aknar Calabrich, Luiz Henrique Araujo, Gilberto de Castro Junior, Carolina Bustamante, André Santa Maria, Marcelo Martins Reis, Carlos Gil Ferreira
EGFR Mutation Detection in Brazilian Patients With Non-Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing. JCO global oncology 9 (2023)
Pedro Nazareth Aguiar, Silvio Matsas, Rodrigo Dienstmann, Carlos Gil Ferreira
Challenges and opportunities in building a health economic framework for personalized medicine in oncology. Personalized medicine (2023)
Lilian Dantonino Faroni, Carlos Gil Ferreira, Fabio Ynoe de Moraes, Clarissa Seródio Baldotto, Mauro Zukin, Veronica Aran, Luiz Henrique Araujo
Real-World Evidence of Health Outcomes Related to Lung Stereotactic Body Radiation Therapy in Brazil. JCO global oncology 8 (2022)
Flavia A Duarte, Carlos Gil Ferreira, Rodrigo Dienstmann, Bruno L Ferrari, Matheus Costa E Silva, Pedro Nazareth A Junior, Paulo Guilherme de Oliveira Salles, Paulo Henrique Costa Diniz
Barriers in precision medicine implementation among Advanced Nonsquamous Cell Lung Cancer-patients: A Real-World Evidence Scenario. Journal of market access & health policy 10 (1) (2022)
Veronica Aran, Mariano Zalis, Tatiane Montella, Carlos Augusto Moreira de Sousa, Bruno L Ferrari, Carlos Gil Ferreira
Evaluation of KRAS Concomitant Mutations in Advanced Lung Adenocarcinoma Patients. Medicina (Kaunas, Lithuania) 57 (10) (2021)
Carlos Gil Ferreira, Marcia Datz Abadi, Paula de Mendonça Batista, Fernando Brandão Serra, Rodrigo Buzzatti Peixoto, Lucas Miyake Okumura, Erica Regina Cerqueira
Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non-Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach. JCO global oncology 7 (2021)
Guilherme Jorge Costa, Maria Júlia Gonçalves de Mello, Anke Bergmann, Carlos Gil Ferreira, Luiz Claudio Santos Thuler
Tumor-node-metastasis staging and treatment patterns of 73,167 patients with lung cancer in Brazil. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 46 (1) (2020)
Luiz Henrique Araujo, Clarissa Seródio Baldotto, Gilberto de Castro Junior, Artur Katz, Carlos Gil Ferreira, Clarissa Mathias, Eldsamira Mascarenhas, Gilberto de Lima Lopes, Heloisa de Andrade Carvalho, Jaques Tabacof, Jeovany M Mesa, Luciano de Souza Viana, Marcelo de Souza Cruz, Mauro Zukin, Pedro De Marchi, Ricardo Mingarini Terra, Ronaldo Albuquerque Ribeiro, Vladmir Cláudio Cordeiro de Lima, Gustavo Werutsky, Carlos Henrique Barrios, null null
Lung cancer in Brazil. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 44 (1) (2019)